IAHF List: It is imperative that we send Clint Miller to this conference
to
monitor it, and I'm appealing to you all for help towards that end.
If you
can help, please send a donation to Clint
Miller at 139 Northmont Dr. Statesville, NC 28625. The writing is on
the
wall. If we don't torpedo the NREA, we can kiss the supplement industry
goodbye. The bill hasn't been introduced yet, but it will be, and De
Felice
is VERY dangerous.
In 1990 I was one of a large number of people who had 5 minutes at the
microphone at a public meeting convened by the FDA in the aftermath
of the
passage of the NLEA. FDA was mandated by law to solicit public input
on how
vitamins should be reguated under the new law. People on both sides
of the
issue were in attendance, and you could cut the tension in NIH's Masur
auditorium with a knife.
Ken Mehrling of Sigma Tau Pharmaceuticals was there representing De
Felice,
who's product, Carnitour, they were licensed to sell. "Carnitour" is
an FDA
approved pharmaceutical version of the amino acid l-carnitine. De Felice
and Mehrling want a monopoly on l-carnatine, and I heard Mehrling spout
off
with all kinds of GARBAGE whereby they wanted FDA to ban l-carnatine
and
ONLY allow their product to be sold.
Need I say more? Please read the following VERY carefully, and please
visit
De Felice's website at
http://www.fimdefelice.org/currentconf.html to scope the jerk out.
He used
to work for Pfizer, and was a fellow at NIH. I have talked with him
and
he's a very charming, very greedy guy who unfortunately is also a gifted
shmoozer and he has some BIG BUCKS behind him, as symbolized by his
holding
his meeting at the Waldorf Astoria in New York City, and due to his
being
able to get Senators Frist, Harkin, and Congressman Pallone to attend.
Clint is going to need some $$BUCKS$$ just to get in the door-----
anyone
with deep pockets who may be able to help, please call Clint at
704-924-8615. He's closer than I am, and he's the most experienced
health
freedom lobbyist in the world. He deserves our help in getting to this
event.
The Foundation for Innovation in Medicine (FIM)
10th Nutraceutical Conference
NUTRACEUTICALS &
PHARMACEUTICALS TAKEN
TOGETHER: A NEW HEALTH
SECTOR
plus
A New FIM Congressional Proposal:
The Nutraceutical Research & Education Act
- NREA
November 10-11, 1998
The Waldorf-Astoria
New York
Registration Information
Nutraceuticals (include the legal-regulatory entities dietary supplements,
foods
and medical foods) are being consumed together with pharmaceuticals
by a
large percentage of the U.S. population. We must assume that to a significant
degree, nutraceuticals and pharmaceuticals interact with each other,
having a
significant impact on disease- either beneficially or detrimentally.
There
is little
doubt that this potentially enormous new health sector already exists.
There is
also little doubt that the medical community, health industry, and
federal
government are not addressing this new explosive health sector.
FIM announces a 1 1/2 day conference which will present the current
information on the business and regulatory aspects of foods, medical
foods
and dietary supplements. Also included will be presentations on actual
or
virtual clinical trials of nutraceuticals and pharmaceuticals taken
together. A
medicine versus law panel regarding claims will follow each presentation.
The
physicians will propose claims based on the clinical data itself. The
lawyers
will propose claims based on federal law and regulations.
Products to be discussed are Benecol, Ocean Spray Cranberry Juice, St.
John's Wort, Intelligent Quisine, Zocor, Cispro, Prozac and
Antihypertensive Pharmaceuticals.
The Nutraceutical Research & Education Act - NREA
In 1991 FIM published its white paper, "The Nutraceutical Initiative:
A
Proposal for Economic and Regulatory Reform". In it FIM called for
Congress to enact The Nutraceutical Research & Education Act NREA.
We
believe that this proposal may be a timely solution to the current
state of
confusion which would expedite the establishment of a vigorous
research-oriented nutraceutical industry.
Authorities from various health sectors will participate and make comments
and recommendations on the FIM proposal, including members of Congress,
both the House and the Senate corporate medical and legal thought leaders,
who play key roles in formulating U.S. health policy. There is little
doubt
that
the time has come for new nutraceutical laws and regulations.
NEWS ADVISORY
FDA announced it intends to seize cholesterol
lowering Benecol margarine
and ban it as a dietary supplement.
CONFERENCE PARTICIPANTS
Thomas D. Aarts
Executive Editor, Nutrition Business Journal
Nilo Cater, M.D.
Nutrition Scholar, Center for Human Nutrition,
University of Texas,
Southwestern Medical Center at Dallas
Lyn Ciocca
President, Wellness Resources
Stephen L. DeFelice, M.D.
Chairman, FIM (The Foundation for Innovation in
Medicine)
Grant W. Denison, Jr.
Chairman & CEO, BioMarin Pharmaceutical, Inc.
Senator Bill Frist, M.D. (R-Tenn)
Chairman, Senate Labor and Human Resources Public
Health and Safety
Subcommittee
Carl Germano, RD, CNS, LDN
Vice President Product Development, Solgar Vitamin &
Herbs
Samuel Gershon, M.D.
Professor of Psyehiatry, University of Pittsburgh
Peter Goldman, M.D.
Professor of Health Science, Department of Nutrition,
Harvard School of
Public Health
Enrique J. Guardia, Ph.D.
Former Vice President Technology, General Foods USA
Senator Tom Harkin (D-lowa)
Ranking Member, Senate Appropriations Labor, Health
and Human Services
Subcommittee
Robert A. Hoerr, M.D., Ph.D.
President, Research-based Dietary Ingredient
Association (RDIA) and
President and CEO, GalaGen Inc.
Louis Lasagna, M.D.
Dean, Sackler School of Graduate Biomedical Sciences,
Tufts University
Franklin C. Lowe, M.D., MPH
Associate Clinical Professor of Urology, Columbia
University & Associate
Director, Dept. Urology, St. Luke's/Roosevelt Hospital
Antonio C. Martinez, II, Esq.
Attorney at Law, Government & Regulatory Affairs Counsel
Stephen H. McNamara, Esq.
Hyman, Phelps & McNamara, P.C. and former Associate
Chief Counsel for
Food, FDA
C. Kenneth Mehrling
Executive Vice President, General Manager, Sigma-Tau
Pharmaceuticals,
Inc.
Abbey S. Meyers
President, NORD (National Organization for Rare
Disorders, Inc.)
Representative Frank Pallone (D-NJ)
Member, House Commerce Subcommittee on Health and the
Environment
Lawrence M. Resnick, M.D.
Professor of Medicine & Director of Hypertension,
Wayne State University,
School of Medicine
Jur Strobos, M.D., J.D.
Greenberg Traurig and former Director, Policy
Research, Office of the
Commissioner, FDA
John P. Troup, Ph.D.
Vice President, Scientific Affairs, General Nutrition
Corporation
Joseph M. Valenzano, Jr.
President, CEO & Publisher, Exceptional Parent Magazine
William M. Wardell, M.D., Ph.D.
Senior Scientific Officer & Executive Director of the
Institute for Drug
Research, Covance
Rhonda Witwer
Manager, Business Development, Monsanto
SCHEDULE
Tuesday, November 10th
Moderator: DeFelice
8:30 - 9:00 am
Frist
Nutraceuticals and the Congress
9:00 - 9:30 am
DeFelice
Nutraceutical Revolution Update: Nutraceuticals &
Pharmaceuticals Taken
Together: A New Health Sector; Adriamycin and
Carnitine - A Personal
Experience
9:30 - 10:15 am
McNamara
Foods, Medical Foods & Dictary Supplements:
Regulatory Update on Claims
10:15 - 10:45 am
Break
10:45 - 11:15 am
Aarts
The U.S. Nutraceutical Market Size: Update
11:15 - 11:35 am
Hoerr
Research-based Dietary Ingredient Association (RDIA)
11:35 - 11:45 am
DeFelice
Health vs. Medical Nutraceutical Claims: What's the
Difference?
11:45 - 12:05 pm
Cater
Benecol Plus Zocor and Cholesterol Lowering: An
Actual Case
12:05 - 12:30 pm
Medical-Legal Expert Panel
12:30 - 2:00 pm
Lunch
2:00 - 2:20 pm
Gershon
Prozac Plus St. John's Wort and Antidepressant
Activity: A Virtual Case
2:20 - 2:45 pm
Medical-Legal Expert Panel
2:45 - 3:05 pm
Lowe
Ocean Spray Cranberry Juice plus Cispro and the
Reduction of Urinary Tract
Infections: A Virtual Case
3:05 - 3:30 pm
Medical-Legal Expert Panel
3:30 - 4:00 pm
Break
4:00 - 4:20 pm
Resnick
Intelligent Quisine plus Antihypertensive
Pharmaceuticals and Blood Pressure
Lowering
4:20 - 4:45 pm
Medical-Legal Expert Panel
4:45 - 5:30 pm
Panel: Corporate Risks & Opportunities
5:30 - 7:00 pm
Reception
Wednesday, November 11th
Moderator: DeFelice
8:30 - 9:00 am
Ciocca
Sampling: Current Corporate Nutraceutical Claims
9:00 - 9:30 am
DeFelice
FIM Proposal: The Nutraceutical Research & Education
Act - NREA
9:30 - 10:15 am
Panel: Points of View Re: Nutraceuticals & NREA
(Germano, Guardia,
Lasagna, Martinez, McNamara, Mehrling, Meyer, Troup,
Valenzano, Witwer)
10:15 - 10:30 am
Break
10:30 - 11:15 am
Panel Continuation with Audience Participation
11:15 - 12:00 pm
Congressional Comments (Harkin and Pallone) and
Conclusion
REGISTRATION FEE: $1,545 includes lunch and reception
November
10th. Academic rate: $895. Please make checks payable
to FIM and mail to
411 North Avenue East, Cranford, NJ 07016.
Registrations are also accepted
by phone: 908-272-2967 or fax: 908-272-4583 or here
on line by clicking on
this highlighted text.
******************************************
International Advocates for Health Freedom
2411 Monroe St. #3 Hollywood, FL 33020 USA
800-333-2553, overseas 954-929-2905
fax 954-929-0507, www.iahf.com,
jham@iahf.com
Donations Needed For Trips to DC
To Get FDA Oversight Hearing
Due to Illegal FDA Codex Comments
& for Trips to Europe to Assist
Dr.Rath in Getting Hearing at
International Court of Justice
Against the Pharmaceutical Cartel
*********************************